The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia
暂无分享,去创建一个
I. Shimomura | H. Kaneto | T. Matsuoka | M. Ikeda | O. Iida | M. Takahara | N. Katakami | S. Gorogawa
[1] J. Hamming,et al. Functional status as a prognostic factor for primary revascularization for critical limb ischemia. , 2010, Journal of vascular surgery.
[2] G. Falk,et al. Serum albumin and total lymphocyte count as predictors of outcome in hip fractures. , 2010, Clinical nutrition.
[3] Julie W. Anderson,et al. The Relationship between Hemoglobin A1c Values and Healing Time for Lower Extremity Ulcers in Individuals with Diabetes , 2009, Advances in skin & wound care.
[4] M. Peppa,et al. Advanced glycoxidation products and impaired diabetic wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[5] A. Morabito,et al. Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia , 2009, Diabetes Care.
[6] K. Woo,et al. The biology of chronic foot ulcers in persons with diabetes , 2008, Diabetes/metabolism research and reviews.
[7] I. Baumgartner,et al. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. , 2007, Journal of vascular surgery.
[8] B. Nordestgaard,et al. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome , 2007, Diabetologia.
[9] Vincent Falanga,et al. Wound healing and its impairment in the diabetic foot , 2005, The Lancet.
[10] A. Gottsäter,et al. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. , 2005, Journal of vascular surgery.
[11] D. Fry,et al. Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects , 2005, Critical care medicine.
[12] M. Lepäntalo,et al. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. , 2004, Journal of vascular surgery.
[13] J. Hux,et al. Quantifying the risk of infectious diseases for people with diabetes. , 2003, Diabetes care.
[14] T. Magee,et al. A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[15] P. De Cata,et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects , 2002, Journal of internal medicine.
[16] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[17] P. Desgranges,et al. The Management and Outcome of Critical Limb Ischaemia in Diabetic Patients: Results of a National Survey , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[18] Demetre Labadarios,et al. Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. , 2010, Nutrition.
[19] F. Fowkes,et al. Bypass surgery for chronic lower limb ischaemia. , 2008, The Cochrane database of systematic reviews.
[20] L. Norgren,et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.
[21] R. Rutherford,et al. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of Vascular Surgery.
[22] A. Whittemore. Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.